Literature DB >> 32522853

Shedding-Resistant HIV-1 Envelope Glycoproteins Adopt Downstream Conformations That Remain Responsive to Conformation-Preferring Ligands.

Maolin Lu1, Xiaochu Ma2, Nick Reichard2, Daniel S Terry3, James Arthos4, Amos B Smith5, Joseph G Sodroski6,7, Scott C Blanchard3, Walther Mothes1.   

Abstract

The human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (Env) trimer of gp120-gp41 heterodimers mediates virus entry into CD4-positive (CD4+) cells. Single-molecule fluorescence resonance energy transfer (smFRET) has revealed that native Env on the surface of viruses predominantly exists in a pretriggered conformation (state 1) that is preferentially recognized by many broadly neutralizing antibodies (bNAbs). Env is activated by binding receptor CD4, which drives transitions through a default intermediate conformation (state 2) into the three-CD4-bound open conformation (state 3). The application of smFRET to assess the conformational state of existing Env constructs and ligand complexes recently revealed that all current high-resolution structures correspond to downstream states 2 and 3. The structure of state 1, therefore, remains unknown. We sought to identify conditions whereby HIV-1 Env could be stabilized in the pretriggered state 1 for possible structural characterization. Shedding of gp120, known to severely complicate structural studies, can be prevented by using the uncleaved gp160JR-FL precursor with alterations in the protease cleavage site (R508S/R511S) or by introducing a disulfide bridge between gp120 and gp41 designated "SOS" (A501C/T605C). smFRET demonstrated that both shedding-preventing modifications shifted the conformational landscape of Env downstream toward states 2 and 3. However, both membrane-bound Env proteins on the surface of intact viruses remained conformationally dynamic, responsive to state-stabilizing ligands, and able to be stabilized in state 1 by specific ligands such as the Bristol-Myers Squibb (BMS) entry inhibitors. The here-described identification of state 1-stabilizing conditions may enable structural characterization of the state 1 conformation of HIV-1 Env.IMPORTANCE The HIV-1 envelope glycoprotein (Env) opens in response to receptor CD4 binding from a pretriggered (state 1) conformation through a necessary intermediate to the three-CD4-bound conformation. The application of smFRET to test the conformational state of existing Env constructs and ligand complexes used for high-resolution structures recently revealed that they correspond to the downstream conformations. The structure of the pretriggered Env conformation, preferentially recognized by broadly neutralizing antibodies, remains unknown. Here, we identify experimental conditions that stabilize membrane-bound and shedding-resistant virus Env trimers in state 1, potentially facilitating structural characterization of this unknown conformational state.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  human immunodeficiency virus; smFRET; viral envelope protein; virology

Mesh:

Substances:

Year:  2020        PMID: 32522853      PMCID: PMC7431789          DOI: 10.1128/JVI.00597-20

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  HIV vaccine design and the neutralizing antibody problem.

Authors:  Dennis R Burton; Ronald C Desrosiers; Robert W Doms; Wayne C Koff; Peter D Kwong; John P Moore; Gary J Nabel; Joseph Sodroski; Ian A Wilson; Richard T Wyatt
Journal:  Nat Immunol       Date:  2004-03       Impact factor: 25.606

2.  Site-specific protein labeling by Sfp phosphopantetheinyl transferase.

Authors:  Jun Yin; Alison J Lin; David E Golan; Christopher T Walsh
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

Review 3.  Structure-function relationships of HIV-1 envelope sequence-variable regions refocus vaccine design.

Authors:  Susan Zolla-Pazner; Timothy Cardozo
Journal:  Nat Rev Immunol       Date:  2010-07       Impact factor: 53.106

4.  Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer.

Authors:  Jeong Hyun Lee; Gabriel Ozorowski; Andrew B Ward
Journal:  Science       Date:  2016-03-04       Impact factor: 47.728

5.  Shedding and interspecies type sero-reactivity of the envelope glycopolypeptide gp120 of the human immunodeficiency virus.

Authors:  J Schneider; O Kaaden; T D Copeland; S Oroszlan; G Hunsmann
Journal:  J Gen Virol       Date:  1986-11       Impact factor: 3.891

6.  Release of gp120 Restraints Leads to an Entry-Competent Intermediate State of the HIV-1 Envelope Glycoproteins.

Authors:  Alon Herschhorn; Xiaochu Ma; Christopher Gu; John D Ventura; Luis Castillo-Menendez; Bruno Melillo; Daniel S Terry; Amos B Smith; Scott C Blanchard; James B Munro; Walther Mothes; Andrés Finzi; Joseph Sodroski
Journal:  mBio       Date:  2016-10-25       Impact factor: 7.867

7.  Crystal structures of trimeric HIV envelope with entry inhibitors BMS-378806 and BMS-626529.

Authors:  Marie Pancera; Yen-Ting Lai; Tatsiana Bylund; Aliaksandr Druz; Sandeep Narpala; Sijy O'Dell; Arne Schön; Robert T Bailer; Gwo-Yu Chuang; Hui Geng; Mark K Louder; Reda Rawi; Djade I Soumana; Andrés Finzi; Alon Herschhorn; Navid Madani; Joseph Sodroski; Ernesto Freire; David R Langley; John R Mascola; Adrian B McDermott; Peter D Kwong
Journal:  Nat Chem Biol       Date:  2017-08-21       Impact factor: 15.040

8.  Structural basis of coreceptor recognition by HIV-1 envelope spike.

Authors:  Md Munan Shaik; Hanqin Peng; Jianming Lu; Sophia Rits-Volloch; Chen Xu; Maofu Liao; Bing Chen
Journal:  Nature       Date:  2018-12-12       Impact factor: 49.962

9.  Subunit organization of the membrane-bound HIV-1 envelope glycoprotein trimer.

Authors:  Youdong Mao; Liping Wang; Christopher Gu; Alon Herschhorn; Shi-Hua Xiang; Hillel Haim; Xinzhen Yang; Joseph Sodroski
Journal:  Nat Struct Mol Biol       Date:  2012-08-05       Impact factor: 15.369

10.  A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies.

Authors:  Rogier W Sanders; Ronald Derking; Albert Cupo; Jean-Philippe Julien; Anila Yasmeen; Natalia de Val; Helen J Kim; Claudia Blattner; Alba Torrents de la Peña; Jacob Korzun; Michael Golabek; Kevin de Los Reyes; Thomas J Ketas; Marit J van Gils; C Richter King; Ian A Wilson; Andrew B Ward; P J Klasse; John P Moore
Journal:  PLoS Pathog       Date:  2013-09-19       Impact factor: 6.823

View more
  13 in total

1.  Asymmetric Structures and Conformational Plasticity of the Uncleaved Full-Length Human Immunodeficiency Virus Envelope Glycoprotein Trimer.

Authors:  Shijian Zhang; Kunyu Wang; Wei Li Wang; Hanh T Nguyen; Shuobing Chen; Maolin Lu; Eden P Go; Haitao Ding; Robert T Steinbock; Heather Desaire; John C Kappes; Joseph Sodroski; Youdong Mao
Journal:  J Virol       Date:  2021-09-22       Impact factor: 5.103

2.  Enhancement of CD4 Binding, Host Cell Entry, and Sensitivity to CD4bs Antibody Inhibition Conferred by a Natural but Rare Polymorphism in the HIV-1 Envelope.

Authors:  Annette N Ratcliff; Colin M Venner; Abayomi S Olabode; Jason Knapp; Joshua Pankrac; Iulian Derecichei; Richard M Gibson; Andrés Finzi; Yue Li; Jamie F S Mann; Eric J Arts
Journal:  J Virol       Date:  2022-07-05       Impact factor: 6.549

3.  Characterization of Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Variants Selected for Resistance to a CD4-Mimetic Compound.

Authors:  Saumya Anang; Jonathan Richard; Catherine Bourassa; Guillaume Goyette; Ta-Jung Chiu; Hung-Ching Chen; Amos B Smith; Navid Madani; Andrés Finzi; Joseph Sodroski
Journal:  J Virol       Date:  2022-08-18       Impact factor: 6.549

4.  Regulation of epitope exposure in the gp41 membrane-proximal external region through interactions at the apex of HIV-1 Env.

Authors:  Hannah M Schapiro; Mukta D Khasnis; Koree Ahn; Alexandra Karagiaridi; Stephanie Hayden; Maria E Cilento; Michael J Root
Journal:  PLoS Pathog       Date:  2022-05-18       Impact factor: 7.464

5.  Global Increases in Human Immunodeficiency Virus Neutralization Sensitivity Due to Alterations in the Membrane-Proximal External Region of the Envelope Glycoprotein Can Be Minimized by Distant State 1-Stabilizing Changes.

Authors:  Qian Wang; Florian Esnault; Meiqing Zhao; Ta-Jung Chiu; Amos B Smith; Hanh T Nguyen; Joseph G Sodroski
Journal:  J Virol       Date:  2022-03-15       Impact factor: 6.549

6.  Functional and Highly Cross-Linkable HIV-1 Envelope Glycoproteins Enriched in a Pretriggered Conformation.

Authors:  Hanh T Nguyen; Alessandra Qualizza; Saumya Anang; Meiqing Zhao; Shitao Zou; Rong Zhou; Qian Wang; Shijian Zhang; Ashlesha Deshpande; Haitao Ding; Ta-Jung Chiu; Amos B Smith; John C Kappes; Joseph G Sodroski
Journal:  J Virol       Date:  2022-03-28       Impact factor: 6.549

7.  Dual Pathways of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Trafficking Modulate the Selective Exclusion of Uncleaved Oligomers from Virions.

Authors:  Shijian Zhang; Hanh T Nguyen; Haitao Ding; Jia Wang; Shitao Zou; Lihong Liu; Debjani Guha; Dana Gabuzda; David D Ho; John C Kappes; Joseph Sodroski
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

8.  Spike glycoprotein and host cell determinants of SARS-CoV-2 entry and cytopathic effects.

Authors:  Hanh T Nguyen; Shijian Zhang; Qian Wang; Saumya Anang; Jia Wang; Haitao Ding; John C Kappes; Joseph Sodroski
Journal:  J Virol       Date:  2020-12-11       Impact factor: 5.103

9.  HIV-1 Envelope Glycoproteins Proteolytic Cleavage Protects Infected Cells from ADCC Mediated by Plasma from Infected Individuals.

Authors:  Jérémie Prévost; Halima Medjahed; Dani Vézina; Hung-Ching Chen; Beatrice H Hahn; Amos B Smith; Andrés Finzi
Journal:  Viruses       Date:  2021-11-06       Impact factor: 5.818

10.  Integrating single-molecule spectroscopy and simulations for the study of intrinsically disordered proteins.

Authors:  Jhullian J Alston; Andrea Soranno; Alex S Holehouse
Journal:  Methods       Date:  2021-04-06       Impact factor: 3.608

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.